Minimally-destructive detection of magnetically-trapped atoms using frequency-synthesised light

We present a technique for atomic density measurements by the off-resonant phase-shift induced on a two-frequency, coherently-synthesised light beam. We have used this scheme to measure the column density of a magnetically trapped atom cloud and to monitor oscillations of the cloud in real time by making over a hundred non-destructive local density measurments. For measurements using pulses of 10,000-100,000 photons lasting ~10 microsecond, the precision is limited by statistics of the photons and the photodiode avalanche. We explore the relationship between measurement precision and the unwanted loss of atoms from the trap and introduce a figure of merit that characterises it. This method can be used to probe the density of a BEC with minimal disturbance of its phase.Comment: Submitted to New Journal of Physic

Contrast medium-induced nephropathy, a more practical approach to prevention?

To The Editor: we read with interest the good review article by Drs Sterner and Nyman [1] concerning the safe use of intravascular contrast medium for both coronary interventions and multi-channel detector computed tomography. see the full text of the articl

Cardiovascular changes after administration of aerosolized salbutamol in horses: five cases

Prevention and treatment of intraoperative hypoxemia in horses is difficult and both efficacy and safety of therapeutic maneuvers have to be taken into account. Inhaled salbutamol has been suggested as treatment of hypoxia in horses during general anesthesia, due to safety and ease of the technique. The present report describes the occurrence of clinically relevant unwanted cardiovascular effects (i.e. tachycardia and blood pressure modifications) in 5 horses undergoing general anesthesia in dorsal recumbency after salbutamol inhalation. Balanced anesthesia based on inhalation of isoflurane in oxygen or oxygen and air and continuous rate infusion (CRI) of lidocaine, romifidine, or combination of lidocaine and guaifenesine and ketamine was provided. Supportive measures were necessary to restore normal cardiovascular function in all horses but no long-term adverse effects were noticed in any of the cases

Tapered-amplified AR-coated laser diodes for Potassium and Rubidium atomic-physics experiments

We present a system of room-temperature extended-cavity grating-diode lasers (ECDL) for production of light in the range 760-790nm. The extension of the tuning range towards the blue is permitted by the weak feedback in the cavity: the diodes are anti-reflection coated, and the grating has just 10% reflectance. The light is then amplified using semiconductor tapered amplifiers to give more than 400mW of power. The outputs are shown to be suitable for atomic physics experiments with potassium (767nm), rubidium (780nm) or both, of particular relevance to doubly-degenerate boson-fermion mixtures

On the difference between type E and A OH/IR stars

The observed SEDs of a sample of 60 OH/IR stars are fitted using a radiative transfer model of a dusty envelope. Among the whole sample, 21 stars have reliable phase-lag distances while the others have less accurate distances. L*-P,Mlr-P and Mlr-L* relations have been plotted for these stars. It is found that type E (with emission feature at 10um and type A (with absorption feature at 10um) OH/IR stars have different L*-P and Mlr-L* relations while both of them follow a single Mlr-P relation. The type E stars are proven to be located in the area without large scale dense interstellar medium while the type A stars are located probably in dense interstellar medium. It is argued here that this may indicate the two types of OH/IR stars have different chemical composition or zero age main sequence mass and so evolve in different ways. This conclusion has reinforced the argument by Chen et al.(2001) who reached a similar conclusion from the galactic distribution of about 1000 OH/IR stars with the IRAS low-resolution spectra (LRS).Comment: 6 pages, 9 figures, 2 table

Wearable device to assist independent living.

Older people increasingly want to remain living independently in their own homes. The aim of the ENABLE project is to develop a wearable device that can be used both within and outside of the home to support older people in their daily lives and which can monitor their health status, detect potential problems, provide activity reminders and offer communication and alarm services. In order to determine the specifications and functionality required for development of the device user surveys and focus groups were undertaken and use case analysis and scenario modeling carried out. The project has resulted in the development of a wrist worn device and mobile phone combination that can support and assist older and vulnerable wearers with a range of activities and services both inside and outside of their homes. The device is currently undergoing pilot trials in five European countries. The aim of this paper is to describe the ENABLE device, its features and services, and the infrastructure within which it operates

Renormalization Group Flow Equation at Finite Density

For the linear sigma model with quarks we derive renormalization group flow equations for finite temperature and finite baryon density using the heat kernel cutoff. At zero temperature we evolve the effective potential to the Fermi momentum and compare the solutions of the full evolution equation with those in the mean field approximation. We find a first order phase transition either from a massive constituent quark phase to a mixed phase, where both massive and massless quarks are present, or from a metastable constituent quark phase at low density to a stable massless quark phase at high density. In the latter solution, the formation of droplets of massless quarks is realized even at low density.Comment: 30 pages, 9 figures; typos corrected, section 3 revised, one reference added, two references updated, submitted to Phys. Rev.

Low density molecular gas in the galaxy

The distributions and physical conditions in molecular gas in the interstellar medium have been investigated in both the Galaxy and towards external galaxies. For example, Galactic plane surveys in the CO J =1-0 line with the Columbia 1.2-m telescope and with the Five College Radio Astronomy Observatory (FCRAO) 14-m telescopes have been able to trace spiral arms more clearly than HI surveys have been able to reveal, and indicate that most of molecular mass is contained in Giant Molecular Clouds (GMCs). Extensive maps of the whole Milky Way showed two prominent features, the 4-kpc molecular ring and the Galactic center. The physical conditions in the Galaxy have been studied by comparing the intensity of CO J =1-0 line with those of other lines, e.g., 13CO J =1-0, higher J transitions of CO, and dense gas tracers such as HCO+, CS, and HCN. Previous studies were however strongly biased towards regions where CO emission was known to be intense. The radial distribution of molecular hydrogen shows that most of the H2 gas which is indirectly traced by observations of its associated CO emission, originates from the inner Galaxy (Dame 1993). Extending outwards from a galacto-centric distance of ~7 kpc, the H2 mass surface density decreases dramatically, and HI dominates over H2 in the outer Galaxy. What are physical conditions of molecular gas where the CO emission is relatively weak, and can we really trace all of the molecular gas through obervations of CO? These kinds of problems have not been solved yet, but are addressed in our study

Nucleon-nucleon bremsstrahlung: An example of the impossibility of measuring off-shell amplitudes

For nearly fifty years theoretical and experimental efforts in nucleon-nucleon bremsstrahlung (NN$\gamma$) have been devoted to measuring off-shell amplitudes and distinguishing among various NN potentials on the basis of their off-shell behavior. New experiments are underway, designed specifically to attain kinematics further off shell than in the past, and thus to be more sensitive to the off-shell behavior. This letter shows that, contrary to these expectations, and due to the invariance of the S-matrix under transformations of the fields, the off-shell NN amplitude is as a matter of principle an unmeasurable quantity in NN$\gamma$.Comment: 9 pages, Latex, using RevTeX; Minor wording changes, title changed, version to be published in Phys. Rev. Letter

RESPOND – A patient-centred program to prevent secondary falls in older people presenting to the emergency department with a fall: Protocol for a multi-centre randomised controlled trial

Introduction: Participation in falls prevention activities by older people following presentation to the Emergency Department (ED) with a fall is suboptimal. This randomised controlled trial (RCT) will test the RESPOND program which is designed to improve older persons’ participation in falls prevention activities through delivery of patient-centred education and behaviour change strategies. Design and setting: An RCT at two tertiary referral EDs in Melbourne and Perth, Australia. Participants: Five-hundred and twenty eight community-dwelling people aged 60-90 years presenting to the ED with a fall and discharged home will be recruited. People who: require an interpreter or hands-on assistance to walk; live in residential aged care or >50 kilometres from the trial hospital; have terminal illness, cognitive impairment, documented aggressive behaviour or history of psychosis; are receiving palliative care; or are unable to use a telephone will be excluded. Methods: Participants will be randomly allocated to the RESPOND intervention or standard care control group. RESPOND incorporates: (1) home-based risk factor assessment; (2) education, coaching, goal setting, and follow-up telephone support for management of one or more of four risk factors with evidence of effective intervention; and (3) healthcare provider communication and community linkage delivered over six months. Primary outcomes are falls and fall injuries per-person-year. Discussion: RESPOND builds on prior falls prevention learnings and aims to help individuals make guided decisions about how they will manage their falls risk. Patient-centred models have been successfully trialled in chronic and cardiovascular disease however evidence to support this approach in falls prevention is limited. Trial registration. The protocol for this study is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12614000336684)